Ear News and Research

RSS

Mount Sinai Hospital uses M1 LUMI Bead loaded with doxorubicin for liver cancer treatment

An innovative cancer treatment made of luminescent chemotherapy-filled beads injected into tumors through the wrist is now available for patients with inoperable and difficult-to-treat liver cancer.

23 Mar 2016

USF receives $9 million NIH grant to study unique treatment for age-related hearing loss

Researchers in the University of South Florida's Global Center for Hearing and Speech Research, recognized as the world's top research center for age-related hearing loss, have received a five-year, $9 million grant from the National Institutes of Health to study two unique ways to treat age-related hearing loss (ARHL).

17 Mar 2016

UCSF study marks important step toward finding cure for Ebola

In experiments carried out partly at the Department of Energy's SLAC National Accelerator Laboratory, scientists have determined in atomic detail how a potential drug molecule fits into and blocks a channel in cell membranes that Ebola and related "filoviruses" need to infect victims' cells.

15 Mar 2016

Anticancer drug restores hearing in neurofibromatosis patients

In a small clinical study with an anticancer drug that halts blood vessel growth, a handful of people with neurofibromatosis type 2 (NF2) and hearing loss had restoration of hearing.

15 Mar 2016

Enhanced diet helps slow progression of hereditary deafness

An enhanced diet helped reduce hearing loss in mice with the genetic mutation most commonly responsible for childhood deafness, new research suggests.

11 Mar 2016

Light therapy lessens depressive symptoms among cancer survivors

Light therapy decreased depressive symptoms and normalized circadian rhythms among cancer survivors, according to new research from the Icahn School of Medicine at Mount Sinai presented today at the American Psychosomatic Society in Denver, CO.

11 Mar 2016

Hematopoietic reprogramming can lead to differentiated blood products for cell-replacement therapy

Building upon previous work, researchers at the Icahn School of Medicine at Mount Sinai identified cells in the embryos of mice that are precursors to blood stem cells or hematopoietic stem/progenitor cells.

9 Mar 2016

Low level of physical fitness in early life associated with Type 2 Diabetes risk in adulthood

The combination of low aerobic capacity and low muscle strength at age 18 is associated with a three times greater risk of developing Type 2 Diabetes in adulthood, according to new research from the Icahn School of Medicine at Mount Sinai published online today in the journal Annals of Internal Medicine.

8 Mar 2016

Research highlights how the brain handles numbers

Small numbers are processed in the right side of the brain, while large numbers are processed in the left side of the brain, new research suggests.

4 Mar 2016

Researchers reveal link between mitochondrial dysfunction and Fuchs' Endothelial Corneal Dystrophy

Researchers at Schepens Eye Research Institute of Massachusetts Eye and Ear have shown a link between mitochondrial dysfunction in corneal endothelial cells and the development of Fuchs' Endothelial Corneal Dystrophy.

4 Mar 2016

Geneticists explore evolution of musical aptitude

Geneticists at the University of Helsinki and the National University of Singapore have teamed up to explore the evolution of musical aptitude in the first-ever empirical study of the evolution of music.

3 Mar 2016

Blueberry Therapeutics set to create safe, effective nanomedicines to tackle unmet healthcare needs

Blueberry Therapeutics Ltd, a leading pharmaceutical company focused on the major medical problems of inflammation and infection, are exploring the anti-microbial agenda through the development of new anti-fungal drugs and treatments to tackle this important unmet healthcare need.

2 Mar 2016

New WHO report highlights ways to prevent, mitigate hearing loss in children

Nearly 32 million children across the world live with disabling hearing loss. A new World Health Organization (WHO) report, Childhood hearing loss: act now, here’s how, suggests that 60% of this can be prevented.

2 Mar 2016

Romosozumab for postmenopausal women with osteoporosis meets co-primary endpoints in Phase 3 study

Amgen and UCB today announced top-line results from the Phase 3 placebo-controlled FRActure study in postmenopausal woMen with ostEoporosis (FRAME).

22 Feb 2016

Sanford Health clinical trial testing effectiveness of investigational cancer drug nivolumab

People with Merkel cell, gynecological, gastric and head and neck cancers may be eligible to participate in a clinical trial at Sanford Health testing the effectiveness of an investigational drug called nivolumab.

18 Feb 2016

Providence Health System earns Baby-Friendly designation

Providence Health System, the longest continually serving hospital in Washington, D.C. – and a part of Ascension, the nation's largest Catholic and non-profit health system – announced today its designation as a Baby-Friendly hospital.

17 Feb 2016

Wake Forest Baptist scientists prove feasibility of printing living tissue structures for surgical implantation

Using a sophisticated, custom-designed 3D printer, regenerative medicine scientists at Wake Forest Baptist Medical Center have proved that it is feasible to print living tissue structures to replace injured or diseased tissue in patients.

15 Feb 2016

Scientists modify plants' defense system to confer resistance to virus

Scientists at Indiana University have modified a plant gene that normally fights bacterial infection to confer resistance to a virus.

15 Feb 2016

Higher intake of food-based vitamin D during pregnancy linked to reduced risk of allergies in children

Higher intake of foods containing vitamin D during pregnancy - but not supplemental vitamin D intake - was associated with reduced risk of development of allergies in children, according to a study led by an investigator from the Icahn School of Medicine at Mount Sinai and published today in The Journal of Allergy and Clinical Immunology.

11 Feb 2016

Favourable safety, disease control for proton radiotherapy in paediatric medulloblastoma

Proton radiotherapy has an acceptable safety and disease control profile in paediatric medulloblastoma patients, according to research published in The Lancet Oncology.

8 Feb 2016